Professional US stock economic sensitivity analysis and beta calculations to understand market correlation and risk exposure. We help you position your portfolio appropriately based on your risk tolerance and market outlook.
As of 2026-04-08, Keros Therapeutics Inc. (KROS) is trading at a current price of $12.5, marking a 2.12% gain on the day. This analysis examines key technical levels, recent market context, and potential future scenarios for the biotech stock, with no recent earnings data available for the company as of this publication. KROS has seen relatively range-bound trading in recent weeks, with price action largely tied to broader biotech sector flows rather than company-specific news. Key takeaways for
Is Keros Therapeutics (KROS) Stock heavily shorted | Price at $12.50, Up 2.12% - Stock Idea Sharing Hub
KROS - Stock Analysis
3703 Comments
1077 Likes
1
Jariah
Active Reader
2 hours ago
Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations and analyst consensus. We help you understand fair value estimates and potential upside or downside scenarios for any stock you are considering. Our platform provides multiple valuation methods, comparable company analysis, and discounted cash flow models. Make smarter valuation decisions with our comprehensive tools and expert projections based on Wall Street research.
👍 99
Reply
2
Henrene
Active Contributor
5 hours ago
I understood enough to panic a little.
👍 87
Reply
3
Esteysi
Community Member
1 day ago
Hard work really pays off, and it shows.
👍 135
Reply
4
Jaterius
Influential Reader
1 day ago
This feels like step 2 forever.
👍 247
Reply
5
Elliyah
Trusted Reader
2 days ago
This deserves a confetti cannon. 🎉
👍 126
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.